Dashboard
Weak Long Term Fundamental Strength with a -8.90% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.32
- The company has been able to generate a Return on Equity (avg) of 1.39% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 19 Cr (Micro Cap)
145.00
35
0.00%
-0.38
1.39%
2.01
Total Returns (Price + Dividend) 
Machhar Industri for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Machhar Industries Faces Intense Selling Pressure Amid Consecutive Losses
Machhar Industries has encountered significant selling pressure, with the stock registering a sharp decline of 5.00% today and exhibiting no buying interest. The persistent downward trend over multiple time frames highlights distress selling signals, as the company’s shares hover close to their 52-week low amid underperformance relative to the broader market and sector peers.
Read More
Machhar Industries Faces Intense Selling Pressure Amid Prolonged Downtrend
Machhar Industries is currently experiencing extreme selling pressure, with the stock registering a lower circuit and an absence of buyers in the market. This distress selling signals a challenging phase for the specialty chemicals company, as it continues to underperform against key benchmarks and sector peers.
Read More
Machhar Industries Surges to Upper Circuit Amid Unprecedented Buying Interest
Machhar Industries witnessed extraordinary buying momentum on 1 Dec 2025, hitting the upper circuit with only buy orders in the queue and no sellers willing to transact. This rare market phenomenon signals intense demand and could potentially extend the circuit scenario over multiple trading sessions.
Read More Announcements 
Disclosure under Regulation 30A of LODR
20-Nov-2025 | Source : BSEGeneral Disclosures Under Regulation 30A of LODR
Board Meeting Outcome for OUTCOME OF BOARD OF DIRECTORS MEETING
11-Nov-2025 | Source : BSEBoard of directors approved the Unaudited Quarterly Standalone and Consolidated Results for the Second Quarter ended as on 30th Sept 2025 and other regular business of the meeting
Disclosure under Regulation 30A of LODR
11-Nov-2025 | Source : BSEBoard of directors approved Unaudited Standalone and Consolidated Quarterly and Half yearly results for the period ended as on 30th Sept 2025 and other regular business of the company
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 3 Schemes (4.11%)
Held by 0 FIIs
Arvind Krishnagopal Machhar (15.63%)
Nagarjuna Finance Limited (3.37%)
35.21%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 1.42% vs -12.47% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -81.82% vs 37.50% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -14.92% vs 4.92% in Sep 2024
Growth in half year ended Sep 2025 is -6.67% vs 7.14% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -0.77% vs -5.69% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -58.82% vs 30.77% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -7.38% vs -1.28% in Mar 2024
YoY Growth in year ended Mar 2025 is -75.00% vs 66.67% in Mar 2024






